Pfizer Inc. (PFE) is a biopharmaceutical company
with operations throughout the world. The business of the company is divided
into two areas: biopharmaceutical and other products, with the latter largely
comprising of animal health and healthcare.
Business segment:
The biopharmaceutical business is the major
segment of the company and in the first quarter of 2013, it constituted around
85.53% of the revenue, followed by the other products segment which contributes
around 14.47% of the revenues. The
biopharmaceutical business has five business segments which include: Primary
Care (23.99%), Specialty Care (23.44%), Oncology (2.76%), Established Products
(17.93%) and Emerging Markets (17.42%).
The other products segment includes animal health care (8.07%), consumer
health care (6.01%) and other products (0.39%).
Geographical expansion:
The United States contributes the 40% of the
company’s revenue, followed by Europe (22%), emerging markets (22%), and the
rest of the world (16%). After the United States, Japan is the second biggest
market of the company, constituting around 10% of the revenue.
Pfizer is considered as the research leader in
the pharmaceutical industry as every year the company spends billions of
dollars on research and development. Read more
No comments:
Post a Comment